NM_021828.5:c.457C>T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_021828.5(HPSE2):c.457C>T(p.Arg153*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,461,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_021828.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- urofacial syndrome type 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Ochoa syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_021828.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HPSE2 | NM_021828.5 | MANE Select | c.457C>T | p.Arg153* | stop_gained | Exon 3 of 12 | NP_068600.4 | ||
| HPSE2 | NM_001166246.1 | c.457C>T | p.Arg153* | stop_gained | Exon 3 of 13 | NP_001159718.1 | |||
| HPSE2 | NM_001166244.1 | c.457C>T | p.Arg153* | stop_gained | Exon 3 of 11 | NP_001159716.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HPSE2 | ENST00000370552.8 | TSL:1 MANE Select | c.457C>T | p.Arg153* | stop_gained | Exon 3 of 12 | ENSP00000359583.3 | ||
| HPSE2 | ENST00000370546.5 | TSL:1 | c.457C>T | p.Arg153* | stop_gained | Exon 3 of 13 | ENSP00000359577.1 | ||
| HPSE2 | ENST00000370549.5 | TSL:1 | c.457C>T | p.Arg153* | stop_gained | Exon 3 of 11 | ENSP00000359580.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 250432 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1461090Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 726840 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Urofacial syndrome type 1 Pathogenic:2
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 89). This premature translational stop signal has been observed in individual(s) with clinical features of urofacial syndrome (PMID: 20560210, 27151922). This variant is present in population databases (rs267606865, gnomAD 0.005%). This sequence change creates a premature translational stop signal (p.Arg153*) in the HPSE2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HPSE2 are known to be pathogenic (PMID: 20560210, 25510506).
Congenital anomaly of kidney and urinary tract Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at